Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast CancerJ. Clin. Oncol 2022 Aug 26;[EPub Ahead of Print], HS Rugo, A Bardia, F Marmé, J Cortes, P Schmid, D Loirat, O Trédan, E Ciruelos, F Dalenc, PG Pardo, KL Jhaveri, R Delaney, O Fu, L Lin, W Verret, SM Tolaney
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.